Another group showed that TRIM26 expression was increased in human bladder cancer tissues and cell lines, and knocking down TRIM26 significantly inhibited the proliferation, migration, and invasion of bladder cancer cells through the Akt/GSK3β/β-catenin pathway (Xie et al., 2021). This evidence concerns the gene GSK3B and urinary bladder carcinoma.